2-amino-5-benzoylthiazole NPY antagonists

Details for Australian Patent Application No. 2004263311 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Pflieger, Philippe; Neidhart, Werner; Nettekoven, Matthias Heinrich

Agent Spruson & Ferguson

Pub. Number AU-A-2004263311

PCT Pub. Number WO2005/014592

Priority 03017634.1 12.08.03 EP

Filing date 4 August 2004

Wipo publication date 17 February 2005

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07D 277/42 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/014592 Priority application(s): WO2005/014592

19 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263312-Thiazole derivatives as NPY antagonists

2004263306-Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors